1
|
Cell-free protein synthesis system for bioanalysis: Advances in methods and applications. Trends Analyt Chem 2023. [DOI: 10.1016/j.trac.2023.117015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/07/2023]
|
2
|
Revete A, Aparicio A, Cisterna BA, Revete J, Luis L, Ibarra E, Segura González EA, Molino J, Reginensi D. Advancements in the Use of Hydrogels for Regenerative Medicine: Properties and Biomedical Applications. Int J Biomater 2022; 2022:3606765. [PMID: 36387956 PMCID: PMC9663251 DOI: 10.1155/2022/3606765] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2022] [Revised: 08/29/2022] [Accepted: 10/05/2022] [Indexed: 07/29/2023] Open
Abstract
Due to their particular water absorption capacity, hydrogels are the most widely used scaffolds in biomedical studies to regenerate damaged tissue. Hydrogels can be used in tissue engineering to design scaffolds for three-dimensional cell culture, providing a novel alternative to the traditional two-dimensional cell culture as hydrogels have a three-dimensional biomimetic structure. This material property is crucial in regenerative medicine, especially for the nervous system, since it is a highly complex and delicate structure. Hydrogels can move quickly within the human body without physically disturbing the environment and possess essential biocompatible properties, as well as the ability to form a mimetic scaffold in situ. Therefore, hydrogels are perfect candidates for biomedical applications. Hydrogels represent a potential alternative to regenerating tissue lost after removing a brain tumor and/or brain injuries. This reason presents them as an exciting alternative to highly complex human physiological problems, such as injuries to the central nervous system and neurodegenerative disease.
Collapse
Affiliation(s)
- Andrea Revete
- Biological Engineering, Faculty of Biosciences and Public Health, Universidad Especializada de las Americas (UDELAS), Panama City, Panama
- Biomedical Engineering, Faculty of Health Sciences and Engineering, Universidad Latina de Panama (ULATINA), Panama City, Panama
| | - Andrea Aparicio
- Biological Engineering, Faculty of Biosciences and Public Health, Universidad Especializada de las Americas (UDELAS), Panama City, Panama
| | - Bruno A. Cisterna
- Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA
| | - Javier Revete
- Experimentia S.A, Development of Innovative Strategies in Biomedicine and Sustainable Development, Panama, Panama
| | - Luis Luis
- Experimentia S.A, Development of Innovative Strategies in Biomedicine and Sustainable Development, Panama, Panama
| | - Ernesto Ibarra
- Biomedical Engineering, Faculty of Health Sciences and Engineering, Universidad Latina de Panama (ULATINA), Panama City, Panama
| | | | - Jay Molino
- Biological Engineering, Faculty of Biosciences and Public Health, Universidad Especializada de las Americas (UDELAS), Panama City, Panama
| | - Diego Reginensi
- Biological Engineering, Faculty of Biosciences and Public Health, Universidad Especializada de las Americas (UDELAS), Panama City, Panama
- Biomedical Engineering, Faculty of Health Sciences and Engineering, Universidad Latina de Panama (ULATINA), Panama City, Panama
- Integrative Neurobiology, School of Medicine, Universidad de Panama (UP), Panama, Panama
- Center for Biodiversity and Drug Discovery, INDICASAT-AIP, City of Knowledge, Panama, Panama
| |
Collapse
|